幹細胞アッセイの北米市場

◆英語タイトル:NORTH AMERICA STEM CELL ASSAY MARKET FORECAST 2017-2025
◆商品コード:INKW704081
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2017年4月1日
◆ページ数:54
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD1,950 ⇒換算¥218,400見積依頼/購入/質問フォーム
Multi LicenseUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、幹細胞アッセイの北米市場について調査・分析し、幹細胞アッセイの北米市場動向、市場予測、セグメント別分析、市場規模、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

KEY FINDINGSThe North America stem cell assay market is expected to grow $1082 million by 2025. The market growth is expected at the CAGR of 21.69% in the forecast period. The base year considered for the market study is 2016. Rise in the adoption of stem cell assay, the evolvement of technology and increase spending in the stem cell assay market are the key drivers in the North America stem cell assay market.
MARKET INSIGHTS
The North America stem cell assay market is segmented on the basis of types of assay, product, kits, application, end-user and geography. The North America stem cell assay market by type is segmented into cell viability and toxicity assays, isolation and purification assays, cell identification assays, cell differentiation assays, cell function assays and cell apoptosis assays. The product of North America stem cell assay market is segmented into instruments and detection kits. The kits of stem cell assay market are further segmented into adult stem cell kits, human embryonic stem cell kit. The stem cell market by application is further bifurcated into regenerative medicine and therapy development, drug discovery and development and clinical research market. The end-user of stem cell market is segmented into research institutes and industry research. The North America stem cell assay market by geography is segmented into US, Canada, and rest of North America. Increasing Adoption of Stem Cell Assay, improvement in the Technology, high expense in Stem Cell Research are the major drivers for the market growth in North America region. The rise in the adoption of stem cell assay for drug screening & testing is one of the major reasons driving the industry research

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. UNITED STATES IS THE FASTEST GROWING STEM CELL ASSAY MARKET
3.2.2. INDUSTRY RESEARCH IS THE LEADING END-USER SEGMENT
3.2.3. DEMAND FOR REGENERATIVE MEDICINE
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. RISING ADOPTION OF STEM CELL ASSAY
4.1.2. IMPROVEMENT IN TECHNOLOGY
4.1.3. SPENDING IN STEM CELL RESEARCH
4.2. MARKET RESTRAINTS
4.2.1. HIGH COST FOR TREATMENT
4.2.2. SLOW RESPONSE TIME OF REGULATORY BODIES
4.3. MARKET OPPORTUNITIES
4.3.1. CHANGING MARKET DYNAMICS
4.4. MARKET CHALLENGES
4.5. ISSUE IN THE PATIENT’S IMMUNE SYSTEM
5. MARKET SEGMENTATION
5.1. BY TYPES OF ASSAY
5.1.1. CELL VIABILITY & TOXICITY ASSAYS
5.1.2. ISOLATION/PURIFICATION ASSAYS
5.1.3. CELL IDENTIFICATION ASSAYS
5.1.4. CELL DIFFERENTIATION ASSAYS
5.1.5. CELL FUNCTION ASSAYS
5.1.6. CELL APOPTOSIS ASSAYS
5.2. BY PRODUCT
5.2.1. INSTRUMENTS
5.2.2. DETECTION KITS
5.3. BY KITS
5.3.1. ADULT STEM CELL KITS
5.3.1.1. MESENCHYMAL STEM CELL KITS
5.3.1.2. INDUCED PLURIPOTENT STEM CELL KITS
5.3.1.3. HEMATOPOIETIC STEM CELL KITS
5.3.1.4. NEURONAL STEM CELLS KITS
5.3.1.5. UMBILICAL CORD STEM CELLS
5.3.2. HUMAN EMBRYONIC STEM CELLS KITS
5.4. BY APPLICATION
5.4.1. REGENERATIVE MEDICINE & THERAPY DEVELOPMENT
5.4.1.1. ORTHOPEDIC & MUSCULOSKELETAL SPINE STEM CELL ASSAY)
5.4.1.2. DERMATOLOGY STEM CELL
5.4.1.3. CARDIOVASCULAR STEM CELL ASSAY
5.4.1.4. CENTRAL NERVOUS SYSTEM STEM CELL ASSAY
5.4.1.5. ONCOLOGY STEM CELL ASSAY
5.4.2. DRUG DISCOVERY AND DEVELOPMENT
5.4.3. CLINICAL RESEARCH MARKET
5.5. END USER
5.5.1. RESEARCH INSTITUTES
5.5.2. INDUSTRY RESEARCHCHAP
6. KEY ANALYTICAL
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.5. STRATEGIC RECOMMENDATION & CONCLUSION
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. NORTH AMERICA STEM CELL ASSAY MARKET
7.1.1. UNITED STATES STEM CELL ASSAY MARKET
7.1.2. CANADA STEM CELL ASSAY MARKET
8. COMPANY PROFILES
8.1. PROMEGA CORPORATION
8.1.1. OVERVIEW
8.1.2. PRODUCTS PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.1.4. SCOT ANALYSIS
8.1.5. STRATEGIC ANALYSIS
8.2. CELL BIO LABS, INC.
8.2.1. OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC ANALYSIS
8.3. GE HEALTHCARE
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SCOT ANALYSIS
8.3.4. ANALYSIS
8.4. THERMO FISHER SCIENTIFIC PVT. LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVE
8.4.4. SCOT ANALYSIS
8.4.5. STRATEGIC ANALYSIS
8.5. MERCK MILLIPORE (HOLDING COMPANY IS MERCKKGAA)
8.5.1. OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.5.4. SCOT ANALYSIS
8.5.5. STRATEGIC ANALYSIS
8.6. HEMOGENIX INC.
8.6.1. OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.6.4. STRATEGIC ANALYSIS
8.7. STEMCELL TECHNOLOGIES
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC ANALYSIS
8.8. BIO-RAD
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC ANALYSIS
8.9. R&D SYSTEMS
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. SCOT ANALYSIS
8.9.4. STRATEGIC ANALYSIS
8.10. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.10.4. SCOT ANALYSIS
8.10.5. STRATEGIC ANALYSIS

TABLE LIST

TABLE # 1 NORTH AMERICA STEM CELL ASSAY MARKET BY TYPES OF ASSAY 2017-2025 ($ MILLION)
TABLE # 2 NORTH AMERICA STEM CELL ASSAY MARKET BY CELL VIABILITY & TOXICITY ASSAYS 2017-2025 ($ MILLION)
TABLE # 3 NORTH AMERICA STEM CELL ASSAY MARKET BY ISOLATION/PURIFICATION ASSAYS 2017-2025 ($ MILLION)
TABLE # 4 NORTH AMERICA STEM CELL ASSAY MARKET BY CELL IDENTIFICATION ASSAYS 2017-2025 ($ MILLION)
TABLE # 5 NORTH AMERICA STEM CELL ASSAY MARKET IN CELL DIFFERENTIATION ASSAYS 2017-2025 ($ MILLION)
TABLE # 6 NORTH AMERICA STEM CELL ASSAY MARKET IN CELL FUNCTION ASSAYS 2017-2025 ($ MILLION)
TABLE # 7 NORTH AMERICA STEM CELL ASSAY MARKET BY CELL APOPTOSIS ASSAYS 2017-2025 ($ MILLION)
TABLE # 8 NORTH AMERICA STEM CELL ASSAY MARKET BY PRODUCT 2017-2025 ($ MILLION)
TABLE # 9 NORTH AMERICA STEM CELL ASSAY MARKET BY INSTRUMENTS MARKET 2017-2025 ($ MILLION)
TABLE # 10 NORTH AMERICA STEM CELL ASSAY MARKET BY DETECTION KITS MARKET 2017-2025 ($ MILLION)
TABLE # 11 NORTH AMERICA STEM CELL ASSAY MAREKT BY KITS 2017-2025 ($ MILLION)
TABLE # 12 NORTH AMERICA STEM CELL ASSAY MAREKT BY ADULT STEM CELL KITS 2017-2025 ($ MILLION)
TABLE # 13 NORTH AMERICA HUMAN EMBRYONIC STEM CELLS KITS MARKET 2017-2025 ($ MILLION)
TABLE # 14 NORTH AMERICA STEM CELL ASSSAY MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE # 15 NORTH AMERICA REGENERATIVE AND MEDICINE THARAPY MARKET 2017-2025 ($ MILLION)
TABLE # 16 NORTH AMERICA STEM CELL ASSAY DRUG DISCOVERY APPLICATION MARKET 2017-2025 ($ MILLION)
TABLE # 17 NORTH AMERICA STEM CELL ASSAY CLINICAL RESEARCH MARKET 2017-2025 ($ MILLION)
TABLE # 18 NORTH AMERICA STEM CELL ASSAY MARKET BY END USER 2017-2025($ MILLION)
TABLE # 19 RESEARCH ACTIVITIES ON DEIFFERENT TYPE OF STEM CELLS
TABLE # 20 NORTH AMERICA STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH 2017-2025 ($ MILLION)
TABLE # 21 NORTH AMERICA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
TABLE # 22 FUNDS ALLOCATED FOR RESEARCH ACTIVITIES IN BUDGET 2016

FIGURES LIST
FIGURE # 1 MARKET SHARE OF INDUSTRY RESEARCH IN STEM CELL ASSAY MARKET 2017-2025 (%)
FIGURE # 2 REGENERATIVE MEDICINE & THERAPY DEVELOPMENT BY MARKET SHARE 2016 & 2025 (%)
FIGURE # 3 INVESTMENT BY THE PHARMACY MEMBERS IN RESEARCH AND DEVELOPMENT ($ BILLION)
FIGURE # 4 INVESTMENT ON STEM CELL RESEARCH BY NIH 2013-2016 ($ BILLION)
FIGURE # 5 NORTH AMERICA STEM CELL ASSAY MARKET BY HUMAN EMBRYONIC STEM CELLS 2017-2025 ($ MILLION)
FIGURE # 6 NORTH AMERICA STEM CELL ASSAY APPLICATION MARKET BY REGENERATIVE MEDICINE AND THERAPY 2017-2025 ($ MILLION)
FIGURE # 7 NORTH AMERICA STEM CELL ASSAY APPLICATION MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2017-2025 ($ MILLION)
FIGURE # 8 NORTH AMERICA STEM CELL ASSAY APPLICATION MARKET BY CLINICAL RESEARCH 2017-2025 ($ MILLION)
FIGURE # 9 NORTH AMERICA STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES 2017-2025 ($ MILLION)
FIGURE # 10 NORTH AMERICA STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH 2017-2025 ($ MILLION)
FIGURE # 11 TYPE OF CELL THERAPY IN THE YEAR 2015
FIGURE # 12 CAUSES DEATHS UNDER AGE 70 DUE TO NCD’S 2015
FIGURE # 13 PROJECTED NUMBER OF NEW CANCER CASES AND DEATHS BY SEX IN THE U.S., 2016
FIGURE # 14 NORTH AMERICA STEM CELL ASSAY REGIONAL MARKET BREAKDOWN 2016 & 2025 (%)
FIGURE # 15 UNITED STATES (U.S.) STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)
FIGURE # 16 PREVALENCE OF THE CANCER DISORDERS AMONG THE CANADIAN POPULATION IN 2015
FIGURE # 17 CANADA STEM CELL ASSAY MARKET 2017-2025 ($ MILLION)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 幹細胞アッセイの北米市場(NORTH AMERICA STEM CELL ASSAY MARKET FORECAST 2017-2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆